يعرض 1 - 20 نتائج من 99 نتيجة بحث عن '"HIF-α"', وقت الاستعلام: 0.68s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المصدر: Cancers; Volume 15; Issue 4; Pages: 1316

    مصطلحات موضوعية: ccRCC, HIF-α, VHL, EGFR, MET

    وصف الملف: application/pdf

    Relation: Molecular Cancer Biology; https://dx.doi.org/10.3390/cancers15041316

  5. 5
  6. 6
    Dissertation/ Thesis
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
  14. 14
    Academic Journal

    المؤلفون: Corrado C., Fontana S.

    المساهمون: Corrado C., Fontana S.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32764403; info:eu-repo/semantics/altIdentifier/wos/WOS:000565092900001; volume:21; issue:16; firstpage:1; lastpage:17; numberofpages:17; journal:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES; http://hdl.handle.net/10447/517319

  15. 15
  16. 16
    Academic Journal
  17. 17
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 60, № 3 (2015); 31-36 ; Российский вестник перинатологии и педиатрии; Том 60, № 3 (2015); 31-36 ; 2500-2228 ; 1027-4065 ; undefined

    وصف الملف: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/188/229; Папаян А.В., Жукова Л.Ю. Анемии у детей: руководство для врачей. Ст-Петербург: Питер 2001; 351–358. (Papayan A.V., Zhukova L. Ju. Anemia in children: Guide for Physicians. St-Petersburg: Piter 2001; 351–358.); KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney International 2012; 2: Suppl: 331–335.; Практические клинические рекомендации KDIGO по анемии при хронической болезни почек 2012. Нефро- логия и диализ 2012; 15: 1: 14–53. (Clinical Practice Guideline KDIGO for Anemia in Chronic Kidney Disease 2012. Nefrologiya i dializ 2012; 15: 1: 14–53.); Atkinson M.A., Pierce C.B., Zack R.M. et al. Hemoglobin differences by race in children with CKD. Am J Kidney Dis 2010; 55: 6: 1009–1017.; Koshy S.M., Geary D.F. Anemia in children with chronic kidney disease. Pediat Nephrol 2008; 23: 209–219.; Avner E.D., Harmon W.E., Niaudet P., Yoshikawa N. Pediatric Nephrology. In: R. VanDeVoorde, B.A. Warady. Management of Chronic Kidney Disease, Sixth Completely Revised, Updated and Enlarged Edition, Volume 2. Springer–Verlag Berlin Heidelberg, 2008; 1660–1692.; Atkinson M.A., Furth S.L. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011; 7: 635–641.; Nangaku M., Eckardt K.U. Hypoxia and the HIF system in kid ney disease. J Mol Med 2007; 85: 12: 1325–1330.; Hamed E.A., El-Abaseri T.B., Mohamed A.O. et al. Hypoxia and oxidative stress markers in pediatric patients undergoing hemodialysis: cross section study. BMC Nephrol 2012; 13: 136.; Левина А.А., Макешова А.Б., Мамукова Ю.И. и др. Регуляция гомеостаза кислорода. Фактор, индуцированный гипоксией (HIF) и его значение в гомеостазе кислорода. Педиатрия 2009; 88: 4: 92–97. (Levina A.A., Kasenova A.B., Mamukova Ju.I. at al. Regulation of homeostasis of oxygen. Factor-inducible hypoxia (HIF) and its significance in oxygen homeostasis. Pediatriya 2009; 88: 4: 92–97.); Haase V.H. Hypoxia-inducible factors in the kidney. Am J Physiol Renal Physiol 2006; 291: 271–281.; Gunaratnam L., Bonventre J.V. HIF in kidney disease and development. J Am Soc Nephrol 2009; 20: 9: 1877–1887.; Kimura K., Iwano M., Higgins D.F. et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295: 4: 1023–1029.; Hung T.W., Liou J.H., Yeh K.T. et al. Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys. Indian J Med Res 2013; 137: 1: 102–110.; Bolati D., Shimizu H., Yisireyili M. et al. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB. BMC Nephrology 2013; 14: 56.; Baracco R., Saadeh S., Valentini R. Iron deficiency in children with early chronic kidney disease. Pediat Nephrol 2011; 26: 11: 2077–2080.; Atkinson M.A., Pierce C.B., Fadrowski J.J. Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediat Nephrol 2012; 27: 12: 2275–2283.; Левина А.А., Казюкова Т.В., Цветаева Н.В. Гепсидин как регулятор гомеостаза железа. Педиатрия 2008; 87: 1: 67–74. (Levina A.A., Kochetova T.V., Cvetaeva N.V. Hepcidin as a regulator of iron homeostasis. Pediatriya 2008; 87: 1: 67–74.); Park C.H., Valore E.V., Waring A.J. et al. Hepcidin: a urinary antibacterial peptide synthesized in the liver. J Biol Chem 2001; 276: 11: 7806–7810.; Coyne D.W. Hepcidin: utility as a diagnostic tool and therapeutic target. Kidney Int 2011; 80: 3: 240–244.; Zaritsky J., Young B., Wang H.J. et al. Hepcidin-a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 6: 1051–1056.; Atkinson M.A., Kim J.Y., Roy C.N. et al. Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediat Nephrol 2015; 30: 4: 635–643.; Atkinson M.A., Martz K., Warady B.A., Neu A.M. Risk for anemia in pediatric chronic kidney disease patients: a report of NAPRTCS. Pediat Nephrol 2010; 25: 9: 1699–1706.; Fadrowski J.J., Pierce C.B., Cole S.R. et al. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008; 3: 2: 457–462.; Hollowell J.G., Van Assendelft O.W., Gunter E.W. et al. Hematological and iron-related analytes – reference data for persons aged 1 year and over: United States, 1988–1994. National Center for Health Statistics.Vital Health Stat Vital Health Stat 2005; 247: 1–156.; Staples A.O., Wong C.S., Smith J.M. et al. Anemia and risk of hospitalization in pediatric chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1: 48–56.; Жетишев P.A., Мамбетова А.М. Анемический синдром у детей и подростков с хронической почечной недостаточностью. Педиатрия 2005; 4: 39–41. (Zhetishev P.A., Mambetova A.M. Anemic syndrome in children and adolescents with chronic renal failure. Pediatriya 2005; 4: 39–41.); Маковецкая Г.А., Мазур Л.И., Балашова Е.А. Особенности формирования анемии при хронической болезни почек у детей. Педиатрия 2009; 88: 3: 6–12. (Makovetska G.A., Mazur L.I., Balashova E.A. Features of formation of anemia in chronic kidney disease in children. Pediatriya 2009; 88: 3: 6–12.); Лысова Е.В., Савенкова Н.Д. Эритропоэтин (ЭПО), гипоксией индуцированный фактор (HIF-1α) у детей с анемией при хронической болезни почек (ХБП). Рос вестн перинатол и педиат 2014; 59: 5: Приложение: 107. (Lysova E.V., Savenkova N.D. Erythropoietin (EPO), hypoxia- induced factor (HIF-1α) in children with anemia in chronic kidney disease (CKD). Ros Vestn Perinatol i Pediat 2014; 59: 5: Suppl: 107.); Mitsnefes M.M. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study. J Pediat 2006; 149: 5: 671–675.; Borzych-Duzalka D., Bilginer Y., Ha I.S. et al. Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol 2013; 24: 4: 665–676.; Игнатова М.С., Лебеденкова М.В., Длин В.В. и др. Хронические болезни почек: точка зрения педиатра. Рос вестн перинатол и педиат 2008; 53: 6: 4–10. (Ignatova M.S., Lebedenkova M.V., Dlin V.V. et al. Chronic kidney disease: the point of view of the pediatrician. Ros Vestn Perinatol i Pediat 2008; 53: 6: 4–10.); https://www.ped-perinatology.ru/jour/article/view/188; undefined